BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24176446)

  • 1. Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients.
    Hummel SL; Ghalib HH; Ratz D; Koelling TM
    Am Heart J; 2013 Nov; 166(5):895-903.e1. PubMed ID: 24176446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.
    Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.
    O'Connor C; Fiuzat M; Mulder H; Coles A; Ahmad T; Ezekowitz JA; Adams KF; Piña IL; Anstrom KJ; Cooper LS; Mark DB; Whellan DJ; Januzzi JL; Leifer ES; Felker GM
    Eur J Heart Fail; 2019 Jun; 21(6):770-778. PubMed ID: 30919549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
    Voors AA; Ouwerkerk W; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Ng LL; Metra M; Ter Maaten JM; Lang CC; Hillege HL; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Zwinderman AH
    Eur J Heart Fail; 2017 May; 19(5):627-634. PubMed ID: 28247565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status identifies heart failure outpatients at risk for hospitalization or death.
    Heidenreich PA; Spertus JA; Jones PG; Weintraub WS; Rumsfeld JS; Rathore SS; Peterson ED; Masoudi FA; Krumholz HM; Havranek EP; Conard MW; Williams RE;
    J Am Coll Cardiol; 2006 Feb; 47(4):752-6. PubMed ID: 16487840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-Led Heart Failure Clinics Are Associated With Reduced Mortality but Not Heart Failure Hospitalization.
    Savarese G; Lund LH; Dahlström U; Strömberg A
    J Am Heart Assoc; 2019 May; 8(10):e011737. PubMed ID: 31094284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frailty Assessment in Advanced Heart Failure.
    Madan SA; Fida N; Barman P; Sims D; Shin J; Verghese J; Piña I; Jorde U; Patel SR
    J Card Fail; 2016 Oct; 22(10):840-4. PubMed ID: 26883168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of prior heart failure hospitalizations on long-term mortality differs by baseline risk of death.
    Kommuri NV; Koelling TM; Hummel SL
    Am J Med; 2012 Feb; 125(2):209.e9-209.e15. PubMed ID: 22269626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction.
    Kaufmann D; Szwoch M; Kwiatkowska J; Raczak G; Daniłowicz-Szymanowicz L
    PLoS One; 2019; 14(12):e0225829. PubMed ID: 31790492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.
    Skali H; Dwyer EM; Goldstein R; Haigney M; Krone R; Kukin M; Lichstein E; McNitt S; Moss AJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2014 May; 16(5):560-5. PubMed ID: 24578164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart Failure.
    Simpson J; Jhund PS; Lund LH; Padmanabhan S; Claggett BL; Shen L; Petrie MC; Abraham WT; Desai AS; Dickstein K; Køber L; Packer M; Rouleau JL; Mueller-Velten G; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    JAMA Cardiol; 2020 Apr; 5(4):432-441. PubMed ID: 31995119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification in heart failure decompensation in the community: HEFESTOS score.
    Verdu-Rotellar JM; Abellana R; Vaillant-Roussel H; Gril Jevsek L; Assenova R; Kasuba Lazic D; Torsza P; Glynn LG; Lingner H; Demurtas J; Thulesius H; Muñoz MA;
    ESC Heart Fail; 2022 Feb; 9(1):606-613. PubMed ID: 34811953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Left Atrial Strain in Outpatients with De Novo Heart Failure.
    Sanchis L; Andrea R; Falces C; Lopez-Sobrino T; Montserrat S; Perez-Villa F; Bijnens B; Sitges M
    J Am Soc Echocardiogr; 2016 Nov; 29(11):1035-1042.e1. PubMed ID: 27624593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study.
    Ricci F; Barison A; Todiere G; Mantini C; Cotroneo AR; Emdin M; De Caterina R; Galllina S; Aquaro GD
    Eur Heart J Cardiovasc Imaging; 2018 Aug; 19(8):896-904. PubMed ID: 29045598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score.
    Segar MW; Vaduganathan M; Patel KV; McGuire DK; Butler J; Fonarow GC; Basit M; Kannan V; Grodin JL; Everett B; Willett D; Berry J; Pandey A
    Diabetes Care; 2019 Dec; 42(12):2298-2306. PubMed ID: 31519694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.